Task: Answer the multiple-choice question.
Query: Which compound exhibits a -3.236% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) CC1c2[nH]c3ccccc3c2CCN1S(C)(=O)=O
b.) C/C(=N\Nc1ccccn1)c1ccc(C(C)C)cc1
c.) CN(C)CCCN(C(=O)CCc1ccccc1)c1nc2ccc(Br)cc2s1.Cl
Answer: c. CN(C)CCCN(C(=O)CCc1ccccc1)c1nc2ccc(Br)cc2s1.Cl
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CN(C)CCCN(C(=O)CCc1ccccc1)c1nc2ccc(Br)cc2s1.Cl
CN(C)CCCN(C(=O)CCc1ccccc1)c1nc2ccc(Br)cc2s1.Cl
N-(6-bromo-1,3-benzothiazol-2-yl)-N-[3-(dimethylamino)propyl]-3-phenylpropanamide;hydrochloride